Watchlist Price Alert

aTyr Pharma Inc. (LIFE)

NASDAQ: LIFE · Real-Time Price · USD

1.90

0.05 (2.70%)

At close: Jun 04, 2024, 8:00 PM

aTyr Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	22.54M	9.98M	2.34M	16.95M	9.21M	22.96M	21.09M	38.39M
Short-Term Investments	75.62M	56.16M	105.58M	14.74M	21.93M	26.58M	64.03M	33.76M
Long-Term Investments	3.48M	3.17M	n/a	n/a	n/a	n/a	n/a	4M
Other Long-Term Assets	131K	-22K	n/a	n/a	172K	1.35M	1.96M	-1.05M
Receivables	2.44M	11.78M	435K	2.04M	n/a	n/a	n/a	n/a
Inventory	-78.01M	-2.95M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.39M	2.95M	5.38M	2.02M	781K	1.26M	1.87M	2.62M
Total Current Assets	102.99M	81.09M	113.73M	35.74M	31.93M	49.55M	85.12M	76.15M
Property-Plant & Equipment	14.05M	11.56M	1.81M	2.98M	4.09M	1.85M	2.28M	1.42M
Goodwill & Intangibles	-1	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	19.07M	14.7M	1.81M	2.98M	4.26M	3.2M	4.24M	4.38M
Total Assets	122.07M	95.79M	115.54M	38.73M	36.19M	52.75M	89.36M	80.52M
Account Payables	3.53M	3.11M	1.03M	1.43M	847K	1.04M	2.28M	2.61M
Deferred Revenue	-11.56M	n/a	n/a	n/a	208K	n/a	n/a	n/a
Short-Term Debt	1.33M	894K	980K	861K	9.49M	7.77M	5.01M	339K
Other Current Liabilities	23.12M	9.86M	4M	3.57M	2.38M	2.03M	3.1M	5.58M
Total Current Liabilities	16.42M	13.86M	6.01M	5.86M	12.92M	10.83M	10.39M	8.53M
Long-Term Debt	13.77M	10.64M	398K	1.38M	2.24M	8.26M	14.72M	9.2M
Other Long-Term Liabilities	-1.41M	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Liabilities	15.18M	10.64M	398K	1.38M	2.24M	8.26M	14.72M	9.2M
Total Liabilities	31.6M	24.5M	6.41M	7.24M	15.16M	19.1M	25.11M	17.72M
Total Debt	15.1M	11.53M	1.38M	2.24M	2.99M	16.03M	19.73M	9.54M
Common Stock	63K	29K	28K	11K	4K	31K	30K	24K
Retained Earnings	-468.02M	-417.63M	-372.3M	-338.53M	-322.3M	-298.7M	-264.19M	-215.98M
Comprehensive Income	-74K	-433K	-263K	-43K	-40K	-60K	-120K	-76K
Shareholders Equity	90.66M	71.28M	109.13M	31.48M	21.03M	33.65M	64.25M	62.8M
Total Investments	79.11M	56.16M	105.58M	14.74M	21.93M	26.58M	64.03M	37.76M